B lymphocyte-typing for prediction of clinical response to rituximab

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

(2011) D. E. Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

B cell immunosenescence: different features of naive and memory B cells in elderly

(2011) Silvio Buffa et al.   BIOGERONTOLOGY

Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re-treatment

(2010) E. M. Vital et al.   ARTHRITIS AND RHEUMATISM

Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion

(2010) Edward M. Vital et al.   ARTHRITIS AND RHEUMATISM

Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

(2010) Beatriz Rodríguez-Bayona et al.   ARTHRITIS RESEARCH & THERAPY

B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion

(2009) F. C. Rau et al.   JOURNAL OF IMMUNOLOGY

Class-switched B cells display response to therapeutic B cell depletion in rheumatoid arthritis

(2009) Burkhard Moller et al.   ARTHRITIS RESEARCH & THERAPY

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis

(2009) Maria Rehnberg et al.   ARTHRITIS RESEARCH & THERAPY

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

(2009) M Margarida Souto-Carneiro et al.   ARTHRITIS RESEARCH & THERAPY

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

(2008) Shouvik Dass et al.   ARTHRITIS AND RHEUMATISM

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95

(2008) Annett M. Jacobi et al.   ARTHRITIS AND RHEUMATISM

Phenotypic and functional heterogeneity of human memory B cells

(2008) Iñaki Sanz et al.   SEMINARS IN IMMUNOLOGY